[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.3 ml intradermal on either deltoid for three days in critically ill subjects with COVID-19 diseaseIntervention2: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.1ml intradermal on both deltoids on day 1; followed by randomization to receive 0.1 ml on day 30; in 30 health care workers or close contacts of COVID-19 patientsControl Intervention1: Non-vaccinated health care workers: Till end of study", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.3 ml intradermal on either deltoid for three days in critically ill subjects with COVID-19 disease", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.1ml intradermal on both deltoids on day 1; followed by randomization to receive 0.1 ml on day 30; in 30 health care workers or close contacts of COVID-19 patients", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Non-vaccinated health care workers: Till end of study", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}, {"arm_notes": "", "treatment_id": 843, "treatment_name": "Mycobacterium indicus pranii", "treatment_type": "Microbiota intervention", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 843, "treatment_name": "Mycobacterium indicus pranii", "treatment_type": "Microbiota intervention", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.3 ml intradermal on either deltoid for three days in critically ill subjects with COVID-19 diseaseIntervention2: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.1ml intradermal on both deltoids on day 1; followed by randomization to receive 0.1 ml on day 30; in 30 health care workers or close contacts of COVID-19 patientsControl Intervention1: Non-vaccinated health care workers: Till end of study", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.3 ml intradermal on either deltoid for three days in critically ill subjects with COVID-19 disease", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Mycobacterium Indicus Pranii (MIP) Vaccine: 0.1ml intradermal on both deltoids on day 1; followed by randomization to receive 0.1 ml on day 30; in 30 health care workers or close contacts of COVID-19 patients", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Non-vaccinated health care workers: Till end of study", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]